ADC Therapeutics SA Quarterly Common Stock, Par or Stated Value Per Share in CHF/shares from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: CHF/shares
Description
Face amount or stated value per share of common stock.
Summary
ADC Therapeutics SA quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2022 to Q4 2024.
  • ADC Therapeutics SA Common Stock, Par or Stated Value Per Share for the quarter ending December 31, 2024 was 0.08 CHF/shares, unchanged year-over-year.
Common Stock, Par or Stated Value Per Share, Quarterly (CHF/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.